- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
Prometheus Biosciences Inc is a biotechnology & medical research business based in the US. Prometheus Biosciences Inc shares (RXDX) are listed on the NASDAQ and all prices are listed in US Dollars. Prometheus Biosciences Inc employs 97 staff and has a trailing 12-month revenue of around $4 million.
What's in this guide?
- RXDX shares summary
- Compare share dealing platforms
- Is RXDX stock a buy or sell?
- Stock performance over time
- Can I short RXDX shares?
- Prometheus Biosciences Inc's financials
- How volatile are RXDX shares?
- Does Prometheus Biosciences Inc pay a dividend?
- Have RXDX shares ever split?
- Other common questions
Our top picks for where to buy Prometheus Biosciences stock
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you fund a new account within 30 days
- Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%
How to buy Prometheus Biosciences Inc stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – RXDX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Prometheus Biosciences Inc stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Prometheus Biosciences Inc stock price (NASDAQ: RXDX)
Use our graph to track the performance of RXDX stocks over time.Prometheus Biosciences Inc shares at a glance
Information last updated 2024-06-30.
| 52-week range | $0.00 - $0.00 |
|---|---|
| 50-day moving average | $189.46 |
| 200-day moving average | $112.93 |
| Wall St. target price | $190.00 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-3.54 |
Is it a good time to buy Prometheus Biosciences Inc stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Prometheus Biosciences Inc financials
| Revenue TTM | $4 million |
|---|---|
| Gross profit TTM | $-106,039,000 |
| Return on assets TTM | -20.06% |
| Return on equity TTM | -33.3% |
| Profit margin | 0% |
| Book value | $14.62 |
| Market Capitalization | $9.6 billion |
TTM: trailing 12 months
Prometheus Biosciences Inc share dividends
We're not expecting Prometheus Biosciences Inc to pay a dividend over the next 12 months.
You may also wish to consider:
- Vedanta (VEDL.US) (9.05% forward annual dividend yield)
Have Prometheus Biosciences Inc's shares ever split?
Prometheus Biosciences Inc's shares were split on a 1:100 basis on 31 October 2013 . So if you had owned 100 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Prometheus Biosciences Inc shares – just the quantity. However, indirectly, the new 9900% higher share price could have impacted the market appetite for Prometheus Biosciences Inc shares which in turn could have impacted Prometheus Biosciences Inc's share price.
Prometheus Biosciences Inc share price volatility
Over the last 12 months, Prometheus Biosciences Inc's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Prometheus Biosciences Inc's is -0.4857. This would suggest that Prometheus Biosciences Inc's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Prometheus Biosciences Inc has bucked the trend.
To put Prometheus Biosciences Inc's beta into context you can compare it against those of similar companies.
- Verona Pharma PLC ADR (VRNA.US): 0.424
- Fate Therapeutics (FATE.US): 1.879
- Vedanta (VEDL.US): 1.591
Prometheus Biosciences Inc overview
Prometheus Biosciences, Inc. , a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of novel therapeutics for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial for the treatment of ulcerative colitis and Crohn's disease, as well as systemic sclerosis-associated interstitial lung disease. The company also develops PR300, a G-protein coupled receptor modulator for IBD and potentially other immune-mediated diseases; PRA052, an anti-CD30L mAb for IBD; PR1100, an anti-cytokine receptor mAb for IBD and other immune-mediated diseases; and PR2100, an anti-inflammatory cytokine mAb for IBD, and inflammatory and fibrotic diseases. It has a diagnostics development and collaboration agreement with Takeda Pharmaceutical Company Limited; co-development and manufacturing agreement with Dr. Falk Pharma GmbH for PRA052; license agreement with Cedars-Sinai Medical Center; and strategic collaboration with Millennium Pharmaceuticals, Inc. The company was formerly known as Precision IBD, Inc.
Frequently asked questions
What percentage of Prometheus Biosciences Inc is owned by insiders or institutions?Currently 16.609% of Prometheus Biosciences Inc shares are held by insiders and 81.014% by institutions. How many people work for Prometheus Biosciences Inc?
Latest data suggests 97 work at Prometheus Biosciences Inc. When does the fiscal year end for Prometheus Biosciences Inc?
Prometheus Biosciences Inc's fiscal year ends in December. Where is Prometheus Biosciences Inc based?
Prometheus Biosciences Inc's address is: 9410 Carroll Park Drive, San Diego, CA, United States, 92121 What is Prometheus Biosciences Inc's ISIN number?
Prometheus Biosciences Inc's international securities identification number is: US74349U1088
More resources on Finder
More guides on Finder
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
Sweep Accounts
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 Best Day Trading Apps of 2024
These are the best day trading apps, according to Finder’s comprehensive analysis.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
5 Top Graphene Stocks to Invest in Today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
Ratings methodology for online brokers
Our star ratings for online brokerages are based on how they stack up in nine key categories.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to Invest $10K
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question